UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
PLURISTEM
THERAPEUTICS INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
98-0351734
|
|
(State
of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
|
|
|
|
MATAM
Advanced Technology Park,
Building
No. 20, Haifa, Israel
|
31905
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Title
of Each Class
|
Name
of Each Exchange on Which
|
|
to
be so Registered
|
Each
Class is to be Registered
|
|
|
|
|
Common
Stock, par value $0.00001 per share
|
The
NASDAQ Stock Market LLC
|
If
this
form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction
A.(c), check the following box.
[X]
If
this
form relates to the registration of a class of securities pursuant to Section
12(g) of the Exchange Act and is effective pursuant to General Instruction
A.
(d), check the following box. [ ]
Securities
Act registration statement file number to which this form relates:
N/A
(if
applicable)
Securities
to be registered pursuant to Section 12(g) of the Act: None
Common
Stock, $0.00001 par value per share.
ITEM
1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE
REGISTERED
.
The
Company's authorized common stock consists of 7,000,000 shares with a par value
of $0.00001 per share. All shares have equal voting rights and are entitled
to
one vote per share in all matters to be voted upon by stockholders. The shares
have no pre-emptive, subscription, conversion or redemption rights and may
be
issued only as fully paid and non-assessable shares. Holders of the common
stock
are entitled to equal ratable rights to such dividends and distributions with
respect to the common stock as may be declared by the Board of Directors out
of
funds legally available.
.
ITEM
2. EXHIBITS
.
|
Exhibit
|
Description
|
|
3.1
|
Articles
of Incorporation (incorporated by reference from the Company’s
registration statement on Form SB-2 filed September 10, 2001).
|
|
3.2
|
Amended
By-laws (incorporated by reference from the Company’s Current Report on
Form 8-K filed January 22, 2007)
|
|
|
|
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the
Registrant has caused this registration statement to be signed on its behalf
by
the undersigned, thereunto duly authorized.
|
|
PLURISTEM
THERAPEUTICS INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/S/
Zami Aberman
|
|
|
|
|
Zami
Aberman
|
|
|
|
|
Chief
Executive Officer
|
|
Date:
December 10, 2007